Liposomal Myricetin Nanoantioxidants Attenuate Methotrexate-Induced Hepatotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis in Rats
Antioxidants · 04.04.2026 · 15 (4) · 452
DOI: 10.3390/antiox15040452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 04.04.2026. Verfasst von Fahad Alshammari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Border University.
Abstract (Originalsprache)
Methotrexate (MTX) is widely used for its chemotherapeutic and immunosuppressive properties, but is limited by oxidative stress-mediated hepatotoxicity. Nanoantioxidant delivery systems can enhance the stability, solubility, and in vivo efficacy of natural antioxidants. This study investigated the hepatoprotective effects of myricetin (MYR), a flavonoid with potent antioxidant activity, and its liposomal nanoantioxidant formulation (MYR-loaded liposomal nanoparticles, MYR-LNPs) against MTX-induced liver injury in male albino Sprague Dawley rats. Sixty rats were randomly allocated to six groups: control, MTX, MYR, MYR-LNPs, and combinations of MTX with MYR-LNPs. MYR-LNPs were successfully formulated and physicochemically characterized, exhibiting a mean particle size of 95.6 nm, a zeta potential of −32 mV, and a narrow polydispersity index, collectively confirming their colloidal stability and suitability for hepatic delivery. MTX markedly disrupted liver function, increasing serum AST, ALT, ALP, and bilirubin and decreasing total protein, albumin, and globulin, whereas co-treatment with MYR-LNPs substantially restored these parameters and outperformed free MYR. MTX-induced oxidative stress, reflected by depleted hepatic GSH and antioxidant enzymes (GPx, SOD, CAT, GST), elevated reactive oxygen species (ROS), malondialdehyde (MDA), and protein carbonyls and downregulated NRF2/HO-1, was significantly counteracted by MYR-LNPs. In addition, MYR-LNPs mitigated MTX-evoked inflammation and nitrosative stress by reducing NF-κB, TNF-α, IL-1β, nitric oxide, and iNOS expression. They corrected apoptotic imbalance by lowering Bax and caspase 3 while increasing Bcl-2. Histopathological and ultrastructural assessments confirmed that MYR-LNPs preserved hepatic architecture and mitochondrial integrity. These findings indicate that MYR-loaded liposomal nanoantioxidants provide superior protection against MTX-induced hepatotoxicity by modulating oxidative stress, inflammation, and apoptosis, supporting their potential as an advanced nanodrug delivery strategy for antioxidant therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.
- Center for Health Research, Northern Border University, Arar 73213, Saudi Arabia.
- Department of Medical Laboratory Technology, College of Nursing and Health Science, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Chemistry, College of Sciences, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Department of Physiology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
ORCID-Profile: Fahad Alshammari, Ekramy M Elmorsy, Abdulrahman S Aldaghmi, Fahd Alaajam, Eida M Alshammari, Mona M Elghareeb, Manal S Fawzy, Noha M Abd El-Fadeal
Förderung
- Northern Border University
Zitieren
APA
Alshammari, F., Elmorsy, E. M., Aldaghmi, A. S., Alaajam, F., Alshammari, E. M., Elghareeb, M. M., Fawzy, M. S., & Abd El-Fadeal, N. M. (2026). Liposomal Myricetin Nanoantioxidants Attenuate Methotrexate-Induced Hepatotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis in Rats. Antioxidants, 15(4), 452. https://doi.org/10.3390/antiox15040452
Vancouver
Alshammari F, Elmorsy EM, Aldaghmi AS, Alaajam F, Alshammari EM, Elghareeb MM, et al. Liposomal Myricetin Nanoantioxidants Attenuate Methotrexate-Induced Hepatotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis in Rats. Antioxidants. 2026;15(4):452. doi:10.3390/antiox15040452
BibTeX
@article{Alshammari2026,
author = {Alshammari, Fahad and Elmorsy, Ekramy M and Aldaghmi, Abdulrahman S and Alaajam, Fahd and Alshammari, Eida M and Elghareeb, Mona M and Fawzy, Manal S and Abd El-Fadeal, Noha M},
title = {Liposomal Myricetin Nanoantioxidants Attenuate Methotrexate-Induced Hepatotoxicity by Modulating Oxidative Stress, Inflammation, and Apoptosis in Rats},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {452},
doi = {10.3390/antiox15040452}
}
EUVIMED